In Focus

Joint statement on the current epidemics of new Coronavirus

Together with IPOPI, INGID, APSID, ASID, ARAPID, CIS, LASID, SEAPID we have worked on... es

IPOPI – ESID Joint Statement: The use of monoclonal antibody treatment for patients with PID in the context of the COVID-19 pandemic

 IPOPI ESID Statement IPOPI – ESID Joint Statement The use of monoclonal antib... es

ESID COVID-19 Statement, March 2022

Since the start of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) p... es
News

Registration for the GOSH Immunology Education Day is open!

We are pleased to announce that the registration for the GOSH Immunology Education Da... es

ASID 2023: Early-Bird registration and Abstract Submission are open!

We are pleased to announce that The African Society of Immunodeficiencies is now acce... es

The 22nd Biennial Meeting of ESID will be held in Maastricht, The Netherlands!

We are excited to announce that the 22nd Biennial Meeting of ESID will be held in 202... es
Events
Shortcuts
Affiliated Societies
Affiliated Societies es
Marseille 2024
ESID 2024 Biennial meeting in Marseille es
Access the Grand Rounds Webinars' recordings here
Access the Grand Rounds Webinars' recordings here es
Registry
ESID Online Registry es
Newsletter
Access ESID’s latest news es